Other recent studies have reported an elevated Nrf2 expression in BC tissues and cells, although the correlation between Nrf2 expression, BC treatment-related markers (ER, PR, and HER2), and BC cell sensitivity to apoptosis were not addressed comprehensively [23,31,76]. Here, NFE2L2 is linked to breast cancer.